ahlam1399
09-07-2016, 06:01 PM
BRIEF-Takeda initiates Phase 3 clinical trial of dengue vaccine candidate (TAK-003)
* Initiates global Phase 3 clinical trial (TIDES) of denguevaccine candidate (TAK-003)http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=Gw6eZPDJXj4:Y6a25SCeUqQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Gw6eZPDJXj4:Y6a25SCeUqQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=Gw6eZPDJXj4:Y6a25SCeUqQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Gw6eZPDJXj4:Y6a25SCeUqQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=Gw6eZPDJXj4:Y6a25SCeUqQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/Gw6eZPDJXj4
* Initiates global Phase 3 clinical trial (TIDES) of denguevaccine candidate (TAK-003)http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=Gw6eZPDJXj4:Y6a25SCeUqQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Gw6eZPDJXj4:Y6a25SCeUqQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=Gw6eZPDJXj4:Y6a25SCeUqQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=Gw6eZPDJXj4:Y6a25SCeUqQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=Gw6eZPDJXj4:Y6a25SCeUqQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/Gw6eZPDJXj4